A Palmitic Acid-Conjugated, Peptide-Based pan-CoV Fusion Inhibitor Potently Inhibits Infection of SARS-CoV-2 Omicron and Other Variants of Concern
Qiaoshuai Lan(Chinese University of Hong Kong), Qian Wang(Shanghai Medical College of Fudan University), Wei Xu(Beijing Geriatric Hospital), Jasper Fuk‐Woo Chan(Hong Kong Science and Technology Parks Corporation), Fanke Jiao(Fudan University), Shibo Jiang(Shanghai Medical College of Fudan University), Shuai Xia(Shanghai Medical College of Fudan University), Kwok‐Yung Yuen(University of Hong Kong - Shenzhen Hospital), Lu Lu(Shanghai Medical College of Fudan University), Jie Zhou(Fudan University), Lijue Wang(Fudan University), Guangxu Zhang(Shanghai Medical College of Fudan University), Jing Pu(University of New Mexico)
Cited by 21
Related Papers
A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster
|The Lancet|2020|9.6k
Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
|The Lancet Infectious Diseases|2020|3.4k
Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan
|Emerging Microbes & Infections|2020|3.3k
Consistent Detection of 2019 Novel Coronavirus in Saliva
|Clinical Infectious Diseases|2020|2k